全文获取类型
收费全文 | 216302篇 |
免费 | 36786篇 |
国内免费 | 2541篇 |
专业分类
耳鼻咽喉 | 5622篇 |
儿科学 | 7157篇 |
妇产科学 | 3493篇 |
基础医学 | 12640篇 |
口腔科学 | 2941篇 |
临床医学 | 33467篇 |
内科学 | 61096篇 |
皮肤病学 | 8299篇 |
神经病学 | 21212篇 |
特种医学 | 8420篇 |
外国民族医学 | 1篇 |
外科学 | 50100篇 |
综合类 | 1103篇 |
现状与发展 | 72篇 |
一般理论 | 72篇 |
预防医学 | 13083篇 |
眼科学 | 4993篇 |
药学 | 5714篇 |
1篇 | |
中国医学 | 86篇 |
肿瘤学 | 16057篇 |
出版年
2024年 | 534篇 |
2023年 | 5041篇 |
2022年 | 1566篇 |
2021年 | 4376篇 |
2020年 | 6713篇 |
2019年 | 3423篇 |
2018年 | 8869篇 |
2017年 | 8407篇 |
2016年 | 9570篇 |
2015年 | 9785篇 |
2014年 | 17545篇 |
2013年 | 18466篇 |
2012年 | 10457篇 |
2011年 | 10600篇 |
2010年 | 13082篇 |
2009年 | 16556篇 |
2008年 | 10429篇 |
2007年 | 9128篇 |
2006年 | 11476篇 |
2005年 | 8540篇 |
2004年 | 7596篇 |
2003年 | 6166篇 |
2002年 | 6164篇 |
2001年 | 4266篇 |
2000年 | 3343篇 |
1999年 | 3768篇 |
1998年 | 4454篇 |
1997年 | 4117篇 |
1996年 | 3909篇 |
1995年 | 3734篇 |
1994年 | 2391篇 |
1993年 | 1997篇 |
1992年 | 1686篇 |
1991年 | 1679篇 |
1990年 | 1282篇 |
1989年 | 1396篇 |
1988年 | 1257篇 |
1987年 | 1050篇 |
1986年 | 1097篇 |
1985年 | 938篇 |
1984年 | 843篇 |
1983年 | 829篇 |
1982年 | 883篇 |
1981年 | 759篇 |
1980年 | 696篇 |
1979年 | 493篇 |
1978年 | 564篇 |
1977年 | 584篇 |
1975年 | 375篇 |
1972年 | 372篇 |
排序方式: 共有10000条查询结果,搜索用时 625 毫秒
41.
42.
Erin C. Tully Jackson M. Gray Sherryl H. Goodman Stephen Nowicki Jr. 《Early child development and care》2016,186(12):1939-1951
Children who expect they can bring about good outcomes and avoid bad outcomes tend to experience more personal successes. Little is known about factors that contribute to these ‘control expectancies’. The purpose of the present study was to determine whether children's internal control expectancies occur in the context of parents’ internal control expectancies, low family strain, and high family cohesiveness and whether these factors are more strongly related to daughters’ than sons’ control expectancies. A community sample of 85 children aged 9–11 years and their parents (85 mothers; 63 fathers) completed rating scales. Fathers’ more internal control expectancies and mothers’ reports of fewer family strains were associated with daughters’ but not sons’ greater internal control expectancies, and greater family cohesiveness was related to both daughters’ and sons’ internal control orientations. These findings suggest that family factors may contribute to children's, particularly daughters’, development of internal control expectancies. 相似文献
43.
Edward J. Holland Walter O. Whitley Kenneth Sall Stephen S. Lane Aparna Raychaudhuri Steven Y. Zhang 《Current medical research and opinion》2016,32(10):1759-1765
Objective: Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED).Research design and methods: Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were randomized (1:1) to lifitegrast 5.0% or matching placebo. Changes from baseline to day 84 in signs and symptoms of DED were analyzed.Main outcome measures: Phase 2, pre-specified endpoint: inferior corneal staining score (ICSS; 0–4); OPUS-1, coprimary endpoints: ICSS and visual-related function subscale (0–4 scale); OPUS-2, coprimary endpoints: ICSS and eye dryness score (EDS, VAS; 0–100).Results: Fifty-eight participants were randomized to lifitegrast 5.0% and 58 to placebo in the phase 2 trial; 293 to lifitegrast and 295 to placebo in OPUS-1; 358 to lifitegrast and 360 to placebo in OPUS-2. In participants with mild-to-moderate baseline DED symptomatology, lifitegrast improved ICSS versus placebo in the phase 2 study (treatment effect, 0.35; 95% CI, 0.05–0.65; p?=?0.0209) and OPUS-1 (effect, 0.24; 95% CI, 0.10–0.38; p?=?0.0007). Among more symptomatic participants (baseline EDS ≥40, recent artificial tear use), lifitegrast improved EDS versus placebo in a post hoc analysis of OPUS-1 (effect, 13.34; 95% CI, 2.35–24.33; nominal p?=?0.0178) and in OPUS-2 (effect, 12.61; 95% CI, 8.51–16.70; p?<?0.0001).Limitations: Trials were conducted over 12 weeks; efficacy beyond this period was not assessed.Conclusions: Across three trials, lifitegrast improved ICSS in participants with mild-to-moderate baseline symptomatology in two studies, and EDS in participants with moderate-to-severe baseline symptomatology in two studies. Based on the overall findings from these trials, lifitegrast shows promise as a new treatment option for signs and symptoms of DED. 相似文献
44.
Jamaal L. Benjamin MD PhD Rebecca Dennis DO Stacy White Jr MD David Munson MD Sudha A. Anupindi MD Maciej Piskunowicz MD Kassa Darge MD PhD Ami Gokli MD Misun Hwang MD 《Journal of ultrasound in medicine》2020,39(5):1031-1036
Bowel diseases of prematurity, including necrotizing enterocolitis, are dreaded ailments of neonates. Early diagnosis is difficult, with clinical and radiographic findings often inconclusive. We present a novel use of contrast-enhanced ultrasound in detection of pediatric bowel disease. Early identification of compromised blood flow or an at-risk bowel can be quantitatively detected and monitored. This ability has implications for guidance of emerging therapies, allowing targeting of inflammation. These findings represent an advancement in detection of bowel disease in neonates. 相似文献
45.
46.
Maaike van Gerwen MD Naomi Alpert MS Raja Flores MD Emanuela Taioli MD PhD 《American journal of industrial medicine》2020,63(2):115-120
The association between asbestos exposure, mainly in occupational settings, and malignant mesothelioma has been well established; this has prompted several countries to establish mesothelioma epidemiologic surveillance programs often at the request of national agencies. This review compares currently existing mesothelioma registries worldwide to develop a concept model for a US real-time case capture mesothelioma registry. Five countries were identified with a mesothelioma specific registry, including Italy, France, UK, Australia, and South Korea. All, except the UK, used interviews to collect exposure data. Linkage with the national death index was available or was in future plans for all registries. The registries have limited information on treatment, quality of life, and other patient-centered outcomes such as symptoms and pain management. To thoroughly collect exposure data, “real-time” enrollment is preferable; to maximize the capture of mesothelioma cases, optimal coverage, and a simplified consent process are needed. 相似文献
47.
48.
49.
50.